(Photo: Company Website) Global pharma major Lupin Limited on Monday announced its focus on formulating respiratory inhalers by incorporating a propellant with near-zero global warming potential ...

FRANKFURT, Germany, Oct. 28, 2024 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) today announced its focus on formulating respiratory inhalers by incorporating a propellant with near ...

Global pharma major Lupin Limited (Lupin) announced its focus on formulating respiratory inhalers by incorporating a propellant with near-zero global warming potential (GWP). This initiative aims to ...

Lupin's R&D teams are working on products with a near-zero global warming potential propellant FRANKFURT, Germany, Oct. 28, 2024 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin ...

Lupin's R&D teams are working on products with a near-zero global warming potential propellant FRANKFURT, Germany, Oct. 28, 2024 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin ...

pharma major Lupin Limited (Lupin) today announced its focus on formulating respiratory inhalers by incorporating a propellant with near-zero global warming potential (GWP). This initiative aims ...

Lupin's R&D teams are working on products with a near-zero global warming potential propellant FRANKFURT, Germany, Oct. 28, 2024 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) today ...

Richard Dekhuijzen, em, professor of pulmonology at the Radboud university medical center in Nijmegen, the Netherland said, "The development of inhalers with near-zero global warming potential ...